MedPath

Effect of a Single Nights' Wake Followed by Bright Light Therapy for Severe Depression

Not Applicable
Terminated
Conditions
Depression
Interventions
Behavioral: Single night's wake therapy
Other: Treatment as usual - inpatient care
Device: Bright light
Other: Informative meeting
Drug: Treatment as usual - medicine
Registration Number
NCT02503124
Lead Sponsor
Sahlgrenska University Hospital, Sweden
Brief Summary

A randomized controlled trial comparing wake therapy (single night) followed by bright light therapy to treatment as usual.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Depressive episode requiring admission to a psychiatric hospital (including unipolar and bipolar depression).
Exclusion Criteria
  • Psychotic symptoms/agitation
  • Compulsory admission
  • Confusion
  • Active substance use disorder
  • Eye disease preventing bright light therapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Chronobiological interventionBright lightSingle night's wake therapy followed by bright light therapy for a week as add-on treatment to treatment as usual.
Chronobiological interventionSingle night's wake therapySingle night's wake therapy followed by bright light therapy for a week as add-on treatment to treatment as usual.
ControlTreatment as usual - inpatient careTreatment as usual including a private educational meeting in sleep hygiene.
ControlTreatment as usual - medicineTreatment as usual including a private educational meeting in sleep hygiene.
Chronobiological interventionTreatment as usual - inpatient careSingle night's wake therapy followed by bright light therapy for a week as add-on treatment to treatment as usual.
Chronobiological interventionTreatment as usual - medicineSingle night's wake therapy followed by bright light therapy for a week as add-on treatment to treatment as usual.
ControlInformative meetingTreatment as usual including a private educational meeting in sleep hygiene.
Primary Outcome Measures
NameTimeMethod
MADRS-S score reduction of 50%One week

Montgomery Asberg Depression Rating Scale

Secondary Outcome Measures
NameTimeMethod
MADRS-S score at dischargeParticipants will be followed at discharge, an expected average of 2-3 weeks

Montgomery Asberg Depression Rating Scale

MADRS-S score at follow-up10-14 weeks

Montgomery Asberg Depression Rating Scale

ISI score score at dischargeParticipants will be followed at discharge, an expected average of 2-3 weeks

Insomnia Severity Index - Self administered scale of sleep quality

ISI score score at follow-up10-14 weeks

Insomnia Severity Index - Self administered scale of sleep quality

ISI score reduction of 50%One week

Insomnia Severity Index - Self administered scale of sleep quality

Length of stayThe number of days between admission and discharge

Patients will be followed up 10-14 weeks after discharge and the total number of days in inpatient services calculated.

Re-admission10-14 weeks
CGI score10-14 weeks

Clinical global impression

Medication use10-14 weeks

The use of antidepressants, anxiolytics or other psychiatric medication will be registered at follow-up. The number of patients using more than one medication and the dosage will be compared.

Trial Locations

Locations (1)

Sahlgrenska University Hospital

🇸🇪

Gothenburg, Västra Götaland, Sweden

© Copyright 2025. All Rights Reserved by MedPath